Angiotensin inhibition in renovascular disease: a population-based cohort study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Heart Journal

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ahj.2008.05.013PMID 18760140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enalapril versus Triple-Drug Therapy in the Treatment of Renovascular Hypertension

  2012cited by this paper
• Immortal time bias in observational studies of drug effects

  2007cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

  2007cited by this paper
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• Factors affecting long‐term survival following renal artery stenting

  2007cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

  2007cited by this paper
• Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension.

  2007cited by this paper
• Atherosclerotic Renovascular Disease in Older US Patients Starting Dialysis, 1996 to 2001

  2006cited by this paper
• Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.

  2006cited by this paper
• Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease.

  2006cited by this paper
• Potassium disorders--clinical spectrum and emergency management.

  2006cited by this paper
• Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies

  2006cited by this paper
• Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

  2005cited by this paper
• Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study.

  2005cited by this paper
• Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience.

  2005cited by this paper
• Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death

  2005cited by this paper
• Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.

  2005cited by this paper
• Comparison of Coding of Heart Failure and Comorbidities in Administrative and Clinical Data for Use in Outcomes Research

  2005cited by this paper
• Angiotensin-converting enzyme inhibitor usage in patients with incidental atherosclerotic renal artery stenosis.

  2004cited by this paper
• Angiotensin receptor blockers as anti‐hypertensive treatment for patients with diabetes mellitus: meta‐analysis of controlled double‐blind randomized trials

  2004cited by this paper
• Associations Between Renovascular Disease and Prevalent Cardiovascular Disease in the Elderly: A Population-Based Study

  2004cited by this paper
• Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement.

  2004cited by this paper
• Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001.

  2004cited by this paper
• Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

  2004cited by this paper
• Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis

  2003cited by this paper
• Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.

  2003cited by this paper
• Care and Outcomes of Patients Newly Hospitalized for Heart Failure in the Community Treated by Cardiologists Compared With Other Specialists

  2003cited by this paper
• Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction.

  2002cited by this paper
• Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease

  2002cited by this paper
• Prevalence of renovascular disease in the elderly: a population-based study.

  2002cited by this paper
• A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario.

  2002cited by this paper
• Treatment options for renovascular hypertension

  2002cited by this paper
• Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion.

  2002cited by this paper
• Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.

  2001cited by this paper
• Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis

  2001cited by this paper
• The EUROPA Trial: Design, Baseline Demography and Status of the Substudies

  2001cited by this paper
• Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States.

  2001cited by this paper
• Renal-artery stenosis.

  2001cited by this paper
• Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis.

  1999cited by this paper
• Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease.

  1998cited by this paper
• Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition.

  1998cited by this paper
• Taking precautions with ACE inhibitors. A theoretical risk exists in patients with unilateral renal artery stenosis.

  1998cited by this paper
• Towards improved coding of acute myocardial infarction in hospital discharge abstracts: a pilot project.

  1997cited by this paper
• The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

  1996cited by this paper
• ACE inhibitors and unilateral renal artery stenosis--what price?

  1996cited by this paper
• Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible

  1992cited by this paper
• Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril.

  1991cited by this paper
• High-risk patients treated with enalapril maleate: safety considerations.

  1989cited by this paper
• Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.

  1985cited by this paper
• ANGIOTENSIN CONVERTING ENZYME INHIBITION IN RENOVASCULAR HYPERTENSION: FREQUENCY OF REVERSIBLE RENAL FAILURE

  1984cited by this paper
• Enalapril in the treatment of hypertension with renal artery stenosis.

  1983cited by this paper
• Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.

  1983cited by this paper
• The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension

  1982cited by this paper
• [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].

  1981cited by this paper
• Reversible renal failure during treatment with captopril.

  1979cited by this paper

• The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)

  2026cites this paper
• European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins.

  2025cites this paper
• A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients—A Review PART II—Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory

  2024influential citation
• Clinical practice guideline for the management of hypertension in China

  2024cites this paper
• A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients—A Review: Part I—Epidemiology, Risk Factors, and Atherosclerosis-Related Diversities in Elderly Patients

  2024cites this paper
• 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.

  2024cites this paper
• When Revascularization May Be Appropriate in Atherosclerotic Renal Artery Stenosis

  2024cites this paper
• Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024)

  2024cites this paper
• Evaluations of secondary hypertension and laboratory data in the elderly population.

  2024cites this paper
• Endovascular Versus Medical Management of Atherosclerotic Renovascular Disease: Update and Emerging Concepts.

  2023cites this paper
• Pickering Syndrome: An Overlooked Renovascular Cause of Recurrent Heart Failure

  2023cites this paper
• Secondary hypertension: evaluation and management

  2023cites this paper
• [Guidelines for hypertension management in patients with chronic kidney disease in China (2023)].

  2023cites this paper
• Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH)

  2023cites this paper
• Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension.

  2023cites this paper
• Current trends in the use of the renin-angiotensin system blocking drugs in renovascular arterial hypertension

  2022influential citation
• Impact of renal artery stenosis on acute kidney injury and outcomes after heart failure hospitalization.

  2022cites this paper
• Causes, Evaluation, and Treatment of Secondary and Resistant Hypertension

  2022cites this paper
• Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference

  2021cites this paper
• Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  2021cites this paper
• Approach to the Patient with Chronic Kidney Disease and Renovascular Disease

  2020cites this paper
• Management of renovascular hypertension

  2020cites this paper
• Cardiac Consequences of Renal Artery Stenosis

  2020cites this paper
• ESC/ESVS-Guidelines 2017 zur Diagnose und Behandlung der peripheren arteriellen Verschlusskrankheit // ESC-ESCS-Guidelines 2017 for diagnosis and treatment of peripheral arterial occlusive disease

  2019cites this paper
• Novel therapeutic strategies for renovascular disease.

  2019cites this paper
• Task force for the ESC guidelines on peripheral artery disease :

  2019cites this paper
• Kurzfassung der S2k-Leitlinie Erkrankungen der Nierenarterie

  2019cites this paper
• Nefropatías vasculares: hipertensión vasculorrenal y nefropatía isquémica

  2019cites this paper
• ESC guidelines on peripheral artery disease :

  2019cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

  2019cites this paper
• ESC/ESVS-Guidelines 2017 zur Diagnose und Behandlung der peripheren arteriellen Verschlusskrankheit // ESC-ESCS-Guidelines 2017 for diagnosis and treatment of peripheral arterial occlusive disease

  2019cites this paper
• Resistant Hypertension Updated Guidelines

  2019cites this paper
• Renovascular disease

  2019cites this paper
• Is there still a role for renal artery stenting in the management of renovascular hypertension - A single-center experience and where do we stand?

  2019cites this paper
• Sténoses athéromateuses des artères rénales : intérêt de la revascularisation percutanée dans la maladie rénovasculaire sévère

  2019influential citation
• Renal Artery Stenosis

  2019cites this paper
• [Austrian Consensus on High Blood Pressure 2019].

  2019cites this paper
• 13 – Renovascular Hypertension and Ischemic Nephropathy

  2018cites this paper
• Current Concepts in the Treatment of Renovascular Hypertension.

  2018cites this paper
• Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

  2018cites this paper
• Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS)

  2018cites this paper
• Valsartan Effective for Malignant Hypertension after Aortic Dissection with Renal Artery Involvement

  2018cites this paper
• Emerging Paradigms in Chronic Kidney Ischemia.

  2018cites this paper
• Severe Renal Artery Stenosis

  2018cites this paper
• 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b

  2018cites this paper
• Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

  2018cites this paper
• [Doppler ultrasonography of the renal artery: Guidelines and predictive factors for the presence of a tight stenosis. Retrospective analysis of 450 consecutive examinations].

  2018cites this paper
• Macrovascular Involvement in Diabetes: Renal Artery Stenosis

  2018cites this paper
• Renal Arterial Disease and Hypertension.

  2017cites this paper
• [Management of atherosclerotic renal-artery stenosis in 2016].

  2017cites this paper
• Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases , in collaboration with the European Society for Vascular Surgery ( ESVS ) – Web Addenda

  2017cites this paper
• Chapter 2 ROS in Atherosclerotic Renovascular Disease

  2017cites this paper
• ROS in Atherosclerotic Renovascular Disease

  2017cites this paper
• Prise en charge de la sténose athéromateuse d’artère rénale en 2016

  2017cites this paper
• Renal Artery Stenosis: When to Revascularize in 2017.

  2017cites this paper
• Effects of renal angioplasty and angiotensin II receptor antagonism

  2017cites this paper
• Renal artery stenosis: if and when to intervene

  2016cites this paper
• Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review

  2016cites this paper
• Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial

  2016cites this paper
• Chapitre 22 – Artériopathie athéromateuse des artères rénales

  2016cites this paper
• Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease.

  2016cites this paper
• Fibromuscular Dysplasia – A Rare Cause of Reno-Vascular Hypertension

  2016influential citation
• Comparative Effectiveness of Management Strategies for Renal Artery Stenosis

  2016cites this paper
• Mood Disorders in Uncontrolled Hypertension Despite Multiple Anti-Hypertensive Medications: Searching for a Link

  2016cites this paper
• Atherosclerotic Renal Artery Stenosis and Hypertension: Pragmatism, Pitfalls, and Perspectives.

  2016cites this paper
• Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis.

  2015cites this paper
• From the 1990s to CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial results and beyond: does stenting have a role in ischemic nephropathy?

  2015cites this paper
• Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?

  2015cites this paper
• Update on intervention versus medical therapy for atherosclerotic renal artery stenosis.

  2015cites this paper
• Renal artery stenosis.

  2015cites this paper
• Significant Improvement in Clinical Symptoms After Succesfull Percutaneous Revascularization of Chronic Total Renal Artery Occlusion:Case Report

  2015cites this paper
• Research Article Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis

  2015cites this paper
• Use of renin-angiotensin system blockade in patients with renal artery stenosis.

  2014cites this paper
• Use of renin-angiotensin inhibitors in people with renal artery stenosis.

  2014cites this paper
• Revascularization as a treatment to improve renal function

  2014cites this paper
• Hypertension associée aux sténoses de l’artère rénale et aux atteintes rénales parenchymateuses

  2014influential citation
• Dilatation des sténoses athéroscléreuses des artères rénales : la fin de l’histoire ?

  2014cites this paper
• Arterial stiffness in atherosclerotic renovascular hypertension

  2014cites this paper
• [Current management of arterial hypertension].

  2014cites this paper
• A ray of light in the dark: alternative approaches to the assessment and treatment of ischemic nephropathy.

  2014cites this paper
• Diagnosis and treatment of resistant hypertension

  2014cites this paper
• [Angioplasty for atherosclerotic renal artery stenosis: the end of the story?].

  2014influential citation
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

  2014cites this paper
• Renal Artery Stenosis—When To Screen, What To Stent?

  2014cites this paper
• Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease

  2014cites this paper
• Atherosclerotic Renovascular Disease: Epidemiology and Clinical Manifestations

  2014cites this paper
• WITHDRAWN: Update on intervention versus medical therapy for atherosclerotic renal artery stenosis

  2014cites this paper
• Clinical problems in renovascular disease and the role of nuclear medicine.

  2014cites this paper
• Atherosclerotic renal artery stenosis and revascularization

  2014cites this paper
• Where now in the management of renal artery stenosis? Implications of the ASTRAL and CORAL trials

  2014cites this paper
• Revascularization in Experimental Atherosclerotic Renal Artery Stenosis:Role of Mitochondrial Targeted Peptides (Bendavia)

  2013cites this paper
• Ischemic nephropathy Nefropatia isquêmica

  2013cites this paper
• Optimal Medical Management in Patients with Renovascular Hypertension

  2013influential citation
• Blockade of the Renin-Angiotensin System in Hypertensive Patients with Atherosclerotic Renal Artery Stenosis

  2013cites this paper
• Renovascular hypertension: is there still a role for stent revascularization?

  2013cites this paper
• Ischemic Renal Disease

  2013cites this paper
• Mechanisms and treatments for renal artery stenosis.

  2013cites this paper
• Have we new therapeutic strategies in the treatment of renovascular nephropathy?

  2013cites this paper
• Renal Artery Stenosis: Medical Versus Interventional Therapy

  2013cites this paper
• Current views on the management of atherosclerotic renovascular disease

  2012cites this paper